Acquired EGFR L858R mutation following ALK-TKI resistance in lung adenocarcinoma: a case report.

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Xalkori (crizotinib) - Pfizer

conteltinib (SY-707) - Centaurus Biopharma, Shouyao Holdings

http://www.ncbi.nlm.nih.gov/pubmed/41869647

Chunxiang Luo; Mengyuan Dong; Runxiang Yang; Ruofan Chen; Ruying Duan; Susu Qu; Wenying Peng

Mar 25, 2026